Answers are grounded in this paper and cite their sources.
Quantifies the induction of AP sites in supercoiled DNA and mutagenic effects in Salmonella typhimurium, indicating potential health implications.
The abilities of seven electrophilic alkenylbenzene derivatives related to 1'-acetoxysafrole to induce apurinic/apyrimidinic (AP) sites in supercoiled SV40 DNA were quantitated by gel electrophoresis after neutral thermal hydrolysis of DNA adducts with unstable N-glycosidic bonds and putrescine/Mg2+ ion-enhanced cleavage of the adjacent phosphodiester linkages. A 20-fold range in AP site production was observed for this series of closely related electrophiles. Analysis of SV40 DNA modified with [2',3'-3H]-1'-acetoxysafrole indicated that approximately 14% of the total safrole-DNA adducts generated AP sites under the conditions used. Neutral thermal hydrolysis of the modified DNA released a product with the same h.p.l.c. retention time as N7-(isosafrol-3'-yl)guanine. The mutagenic potencies in Salmonella typhimurium strain TA100 of these seven electrophilic alkenylbenzene derivatives covered a 75-fold range (from 0.1 to 7.7 revertants/nmol). Although the mutagenic activities of these electrophiles generally correlated well with the hepatocarcinogenic activities of the parent 1'- or 3'-hydroxy derivatives on administration to preweanling male mice, the mutagenic and carcinogenic activities did not correlate with the abilities to induce AP sites.
No takes yet. Share an insight, caveat, or question.
Wiseman et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: